OVERVIEW & USAGE
Brand name :- Opdivo
Generic name :- Nivolumab
Manufacturer :- Bristol-myers Squibb pharma
Dosage form :- Injection
Strength :- 40mg/4ml
Composition :- Nivolumab
Packaging size :- 1 vial
Indication:- Head and neck cancer, kidney cancer, lung cancer, liver cancer, skin cancer.
Storage conditions:- Store in a cool and dry place.
Description
Opdivo (Nivolumab 100mg) is a prescription medicine used to treat people with certain cancers (lung cancer, liver cancer, skin cancer, head and neck cancer). This medication is also used to treat people with a type of advanced-stage lung cancer that has spread or grown and you have tried chemotherapy and it did not work.
Pharmacodynamics Of Opdivo Injection
A dose ranges from 0.1mg to 20mg administered as a single dose or multiple doses of opdivo (nivolumab) as a 60 minutes intravenous infusion every 2 to 3 weeks. The predicted exposure of opdivo after a 30 minutes infusion is comparable to 60 minutes infusion.
Opdivo (Nivolumab 100mg Injection) Indications
- It is indicated for metastatic small cell lung cancer in patients with progression after platinum-based chemotherapy.
- Indicated for patients with poor-risk, previously untreated advanced renal cell carcinoma.
- Indicated for melanoma in patients with lymph node involvement.